Search research articles
Contact Us
Filters
Showing results (1-10 of 320) with videos related to
Page
of 32
Sort By:
Clinical Epidemiology
|
September 25, 2010
Venous and arterial thrombosis: Two aspects of the same disease?
Paolo Prandoni
ACP Journal Club
|
July 3, 2004
Ximelagatran reduced venous thromboembolism more than warfarin after total knee replacement
Paolo Prandoni
Pathophysiology of Haemostasis and Thrombosis
|
February 5, 2005
Controversial issues in the diagnosis of venous thromboembolism
Paolo Prandoni
Gender Medicine
|
March 23, 2006
Venous thromboembolism risk and management in women with cancer and thrombophilia
Paolo Prandoni
Clinical Advances in Hematology & Oncology : H&O
|
September 21, 2005
The optimal long-term treatment of venous thromboembolism
Paolo Prandoni
Haematologica
|
December 2, 2024
Introduction to the Review Series on venous thromboembolism: emerging issues in pathophysiology and management
Paolo Prandoni
European Journal of Haematology
|
July 28, 2012
Anticoagulant treatment of pulmonary embolism: impact and implications of the EINSTEIN PE study
Paolo Prandoni
Cancer Treatment Reviews
|
September 18, 2002
Cancer and thromboembolic disease: how important is the risk of thrombosis?
Paolo Prandoni
Pathophysiology of Haemostasis and Thrombosis
|
July 21, 2006
Acquired risk factors of venous thromboembolism in medical patients
Paolo Prandoni
Advances in Experimental Medicine and Biology
|
September 14, 2016
The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism
Paolo Prandoni
Page
of 32
Search research articles
Search
Showing results (1-10 of 320) with videos related to
Sort By:
Page
of 32
Clinical Epidemiology
|
September 25, 2010
Venous and arterial thrombosis: Two aspects of the same disease?
Paolo Prandoni
ACP Journal Club
|
July 3, 2004
Ximelagatran reduced venous thromboembolism more than warfarin after total knee replacement
Paolo Prandoni
Pathophysiology of Haemostasis and Thrombosis
|
February 5, 2005
Controversial issues in the diagnosis of venous thromboembolism
Paolo Prandoni
Gender Medicine
|
March 23, 2006
Venous thromboembolism risk and management in women with cancer and thrombophilia
Paolo Prandoni
Clinical Advances in Hematology & Oncology : H&O
|
September 21, 2005
The optimal long-term treatment of venous thromboembolism
Paolo Prandoni
Haematologica
|
December 2, 2024
Introduction to the Review Series on venous thromboembolism: emerging issues in pathophysiology and management
Paolo Prandoni
European Journal of Haematology
|
July 28, 2012
Anticoagulant treatment of pulmonary embolism: impact and implications of the EINSTEIN PE study
Paolo Prandoni
Cancer Treatment Reviews
|
September 18, 2002
Cancer and thromboembolic disease: how important is the risk of thrombosis?
Paolo Prandoni
Pathophysiology of Haemostasis and Thrombosis
|
July 21, 2006
Acquired risk factors of venous thromboembolism in medical patients
Paolo Prandoni
Advances in Experimental Medicine and Biology
|
September 14, 2016
The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism
Paolo Prandoni
Page
of 32